The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know I would argue that lipid lowering drugs uh improve longevity but I don't think I would call them Giro protective because they're kind of just acting not on a Hallmark of Aging but rather on one very specific element which is lipoproteins
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
as opposed to way way way Downstream at the you know in the way that a lipid lowering drug Works where it works on one disease pretty much and it works through you know One path and the proof of that is indeed your aging accelerator that is in fact the proof of Jiro protection it almost becomes the sinanan of a molecule being geroprotective versus simply targeting a disease